Dashboard
Manage Tickers

KDNYCHINOOK THERAPEUTICS, INC.

Nasdaq chinooktx.com


$ 40.38 $ 0.09 (0.22 %)    

Thursday, 10-Aug-2023 16:24:38 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 40.39
$ 40.30
$ 0.00 x 0
$ 0.00 x 0
$ 40.29 - $ 40.50
$ 18.34 - $ 40.51
4,924,994
na
2.89B
$ 1.03
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2023 06-30-2023 10-Q
2 05-09-2023 03-31-2023 10-Q
3 02-27-2023 12-31-2022 10-K
4 11-10-2022 09-30-2022 10-Q
5 08-08-2022 06-30-2022 10-Q
6 05-12-2022 03-31-2022 10-Q
7 03-17-2022 12-31-2021 10-K
8 11-08-2021 09-30-2021 10-Q
9 08-12-2021 06-30-2021 10-Q
10 05-12-2021 03-31-2021 10-Q
11 04-07-2021 12-31-2020 10-K
12 11-05-2020 09-30-2020 10-Q
13 08-03-2020 06-30-2020 10-Q
14 05-04-2020 03-31-2020 10-Q
15 03-09-2020 12-31-2019 10-K
16 11-07-2019 09-30-2019 10-Q
17 08-01-2019 06-30-2019 10-Q
18 05-07-2019 03-31-2019 10-Q
19 02-27-2019 12-31-2018 10-K
20 10-30-2018 09-30-2018 10-Q
21 08-01-2018 06-30-2018 10-Q
22 05-02-2018 03-31-2018 10-Q
23 03-01-2018 12-31-2017 10-K
24 10-31-2017 09-30-2017 10-Q
25 08-02-2017 06-30-2017 10-Q
26 05-02-2017 03-31-2017 10-Q
27 03-01-2017 12-31-2016 10-K
28 11-02-2016 09-30-2016 10-Q
29 08-03-2016 06-30-2016 10-Q
30 05-02-2016 03-31-2016 10-Q
31 03-08-2016 12-31-2015 10-K
32 11-23-2015 09-30-2015 10-Q
33 08-11-2015 06-30-2015 10-Q
34 05-28-2015 03-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benzingas-top-ratings-upgrades-downgrades-for-august-8-2023
Benzinga's Top Ratings Upgrades, Downgrade...
08/08/2023 15:00:33

wedbush-downgrades-chinook-therapeutics-to-neutral-announces-42-price-target
Wedbush Downgrades Chinook Therapeutics to...
08/08/2023 12:41:04

Wedbush analyst Laura Chico downgrades Chinook Therapeutics (NASDAQ:KDNY) from Outperform to Neutral and announces $42 price...

benzingas-top-ratings-upgrades-downgrades-for-august-1-2023
Benzinga's Top Ratings Upgrades, Downgrade...
08/01/2023 15:00:35

expert-ratings-for-chinook-therapeutics
Expert Ratings for Chinook Therapeutics
08/01/2023 12:00:21

wells-fargo-downgrades-chinook-therapeutics-to-equal-weight-raises-price-target-to-40
Wells Fargo Downgrades Chinook Therapeutic...
08/01/2023 10:29:29

Wells Fargo analyst Mohit Bansal downgrades Chinook Therapeutics (NASDAQ:KDNY) from Overweight to Equal-Weight and raises th...

chinook-therapeutics-announced-that-the-first-patient-with-iga-nephropathy-has-been-enrolled-in-the-beyond-phase-3-trial-of-evaluating-the-safety-and-efficacy-of-zigakibart-bion-1301-1301
Chinook Therapeutics Announced That The Fi...
07/28/2023 12:03:12

hc-wainwright--co-reiterates-neutral-on-chinook-therapeutics-maintains-40-price-target
HC Wainwright & Co. Reiterates Neutral on ...
06/21/2023 12:28:37

HC Wainwright & Co. analyst Ed Arce reiterates Chinook Therapeutics (NASDAQ:KDNY) with a Neutral and maintains $40 price...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
06/14/2023 15:01:57

evercore-isi-group-downgrades-chinook-therapeutics-to-in-line-announces-40-price-target
Evercore ISI Group Downgrades Chinook Ther...
06/14/2023 13:19:20

Evercore ISI Group analyst Josh Schimmer downgrades Chinook Therapeutics (NASDAQ:KDNY) from Outperform to In-Line and announ...

benzingas-top-ratings-upgrades-downgrades-for-june-13-2023
Benzinga's Top Ratings Upgrades, Downgrade...
06/13/2023 15:00:52

stifel-downgrades-chinook-therapeutics-to-hold-lowers-price-target-to-41
Stifel Downgrades Chinook Therapeutics to ...
06/13/2023 11:25:53

Stifel analyst Alex Thompson downgrades Chinook Therapeutics (NASDAQ:KDNY) from Buy to Hold and lowers the price target from...

svb-leerink-downgrades-chinook-therapeutics-to-market-perform-lowers-price-target-to-40
SVB Leerink Downgrades Chinook Therapeutic...
06/13/2023 10:16:35

SVB Leerink analyst Joseph Schwartz downgrades Chinook Therapeutics (NASDAQ:KDNY) from Outperform to Market Perform and lowe...

hc-wainwright--co-downgrades-chinook-therapeutics-to-neutral-announces-40-price-target
HC Wainwright & Co. Downgrades Chinook The...
06/13/2023 10:12:40

HC Wainwright & Co. analyst Ed Arce downgrades Chinook Therapeutics (NASDAQ:KDNY) from Buy to Neutral and announces $40 ...

chinook-therapeutics-to-present-updated-data-from-zigakibart-phase-12-trial-in-patients-with-iga-nephropathy-at-the-60th-european-renal-association-congress
Chinook Therapeutics To Present Updated Da...
06/12/2023 20:07:50

Zigakibart treatment continues to demonstrate rapid and sustained reductions in mechanistic biomarkers, including IgA and Gd-Ig...

nasdaq-gains-1-us-budget-deficit-widens-in-may
Nasdaq Gains 1%; US Budget Deficit Widens ...
06/12/2023 18:54:41

U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 100 points on Monday. The Dow traded u...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
06/12/2023 17:31:37

why-asset-entities-shares-are-trading-higher-by-142-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Asset Entities Shares Are Trading High...
06/12/2023 17:03:57

Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI ...

what-6-analyst-ratings-have-to-say-about-chinook-therapeutics
What 6 Analyst Ratings Have To Say About C...
06/12/2023 17:02:42

what-to-know-about-guggenheims-downgrade-of-chinook-therapeutics
What To Know About Guggenheim's Downgrade ...
06/12/2023 17:00:56

cantor-fitzgerald-downgrades-chinook-therapeutics-to-neutral-announces-40-price-target
Cantor Fitzgerald Downgrades Chinook Thera...
06/12/2023 16:43:53

Cantor Fitzgerald analyst Charles Robertson II downgrades Chinook Therapeutics (NASDAQ:KDNY) from Overweight to Neutral and ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION